Maddi Hebebrand
Articles
June 18th 2024
Ritlecitinib Effective For Patients With Alopecia Areata, Improves Hair Regrowth
A poster from the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema (RAVE) conference held in Chicago, Illinois presented results of a clinical trial for patients with alopecia areata (AA). The trial used rilecitinib and showed promising results in patients with AA after most patients achieved significant hair regrowth following 15 months of treatment.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 3rd 2024 | Updated: September 10th 2024
PCOC 2024 Promises to Hit All the High Notes
Published: August 30th 2024 | Updated: September 10th 2024
Symptom-Triggered Testing Detects Early-Stage Ovarian Cancer in 1 in 4 Women
Published: August 31st 2024 | Updated: September 10th 2024
Low Patient Involvement in First-Line Ovarian Cancer Treatment Decisions in Europe, US
Published: August 28th 2024 | Updated: September 10th 2024
Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy
Published: August 4th 2024 | Updated: September 10th 2024
Who Should Have Lp(a) Levels Tested? Experts Take Sides
